Medical Oncology Association of Southern California, Inc.

October is Breast Cancer Awareness Month. We can change breast cancer as we know it through early detection, awareness and timely access to treatments.

MOASC and ANCO present the Immuno-Oncology Symposium in Santa Monica on Saturday, November 11, 2023. Learn about cutting-edge technologies and their optimal clinical application. Stay tuned for more details!

Were continuing to highlight cancer research in So Cal and are excited to acknowledge from as the May for his research in Melanoma. Click here to watch the interview: httpshttps://youtu.be/fa7ZyZ-pS8Y

Don't miss the opportunity to participate in the CME/ABIM MOC-certified virtual event on June 22nd, which is focused on advancing the line with new combination therapies for malignant melanoma. Hear from esteemed faculty who will delve into the latest research, clinical trials, and breakthrough discoveries, providing attendees with invaluable insights into cutting-edge combination therapy strategies. Register now at http://www.clinicaloptions.com/MelanomaLocalChapter2023

We are excited to continue highlighting the great cancer research happening here in So Cal and to acknowledge from as the April for her excellent research in To watch the interview, visit

MOASC's April Researcher of the Month - Dr. Budde, City of Hope Elizabeth Budde, MD, PhD, Associate Professor, Division of Lymphoma, Department of Hematology & Hematopoietic Cell Transplantation, City of Hope discusses he...

We are excited to announce the newest Member to the MOASC Board of Directors - Research interests include , , , and

We are excited to highlight the great cancer research happening right here in So Cal and to acknowledge from as the January for her excellent research in Lymphoma. Interview Link https://youtu.be/ZopC-OouxJo Trial link https://swog.org/clinical-trials/s1918

Congratulations to as the December "Researcher of the Month" for her excellent research in Prostate Cancer/CAR-T trials. To watch the interview and learn more about her research, click here https://youtu.be/b9xjhSxlk10

Join us 12/15 at 5:30pm for a webinar with on the unmet need for patients with Liver Cancer and the study. Register here:

Welcome! You are invited to join a webinar: AstraZeneca Meeting - 20149509. After registering, you will receive a confirmation email about joining the webinar. AstraZeneca Speaker Program

We joined and 47 other state oncology societies to voice our support for H.R. 8800, the Supporting Medicare Providers Act of 2022, and ask Congress to address long term Medicare payment reform. Read the letter:https://old-prod.asco.org/sites/new-www.asco.org/files/ASCO-State-Affiliates-Letter-HR-8800-Final-11.03.22.pdf

old-prod.asco.org

ASCO Announces Election Candidates. Board Member Sumanta Pal, MD, City of Hope is one of the nominees. We strongly encourage you to vote for Dr. Pal. He would be an excellent addition to the Nominating Committee. Vote before 12/6: https://old-prod.asco.org/about-asco/asco-overview/asco-election?cid=DM11490&bid=202495210

Save-the-Date - Saturday, January 28, 2023 MOASC's Annual Spotlight On Hematology in Huntington Beach.
More details to follow soon.

Congratulations to Dr. El-Khoueiry, USC as the October Researcher of the month for his excellent research in GI trials and Phase 1 Drug Development trials. To watch the interview and learn more about his research, click here

Dr. El-Khoueiry, USC October Researcher of the Month Congratulations to Dr. El-Khoueiry, USC as the October Researcher of the month for his excellent research in GI trials and Phase 1 Drug Development trials.

This is great news!

California Gov. Gavin Newsom Signs Law to Improve Cancer Care Equity The new law will provide cancer care equity for the most vulnerable populations in the state to receive optimal cancer care.

Congratulations to Dr. Karen Reckamp, Cedars Sinai Medical Center. We are pleased to acknowledge her as the September Researcher of the month for her excellent work in Lung Cancer Research. To watch the interview and learn more, click here https://youtu.be/QY5OKsvalf8

Join us for the Fall Educational Series Programs:
Part 1 on 10/13 for the Oncology Administrator Webinar. Topics include: Talent Acquisition & Retention; Extinguish Burnout; and How to improve the Patient Collections Experience. Register: https://events.r20.constantcontact.com/register/eventReg?oeidk=a07ejdg1mrs544fba01&oseq=&c=&ch=

Part 2 on 10/27 for the Oncology Billing Webinar. Topics include: Oncology Billing Updates; Noridian Updates; and Social Determinants of Health & Z Codes. Register: https://events.r20.constantcontact.com/register/eventReg?oeidk=a07ejdg1mru69bad500&oseq=&c=&ch=

One of our priorities this year, is to highlight the great cancer research happening right here in Southern California. Therefore, we have been highlighting a “Researcher of the Month” throughout the year.

We are pleased to acknowledge Rana McKay, MD, UCSD as the August for her excellent research in Genitourinary Oncology and Clinical Trials and

To watch the interview and learn more click here https://youtu.be/LlTAmfMesPk

MOASC's August Researcher of the Month - Dr. Rana McKay, UCSD We are pleased to acknowledge Rana McKay, MD, UCSD as the August for her excellent research in Genitourinary Oncology and Clinical T...

Join us TONIGHT at 6pm for a lively discussion of in with and RSVP: [email protected]

Join us for a Clinical Webinar and lively discussion with colleagues on June 16 at 5:30pm to hear from
discuss “An in-depth Overview of Cytopenic Myelofibrosis and VONJO.” RSVP: [email protected]

We are pleased to join Rockpointe Corporation in presenting an on-demand, free CME/CE-certified webcourse on “Nonmelanoma Skin Cancers." This will be available until August of 2022. https://rockpointe.com/courses/nonmelanoma-skin-cancers-current-and-emerging-checkpoint-inhibitors-for-treating-advanced-basal-cell-and-squamous-cell-carcinomas/?utm_source=rp&utm_medium=pm&utm_term=1087

Join us on April 21, 2022 at 5:30pm-PT for a live webinar entitled, Personalized Approaches to HER2-Positive Breast Cancer Treatment. This CME/CNE-certified, ABIM MOC-eligible live activity will provide oncology clinicians with information on the most recent treatments for HER2-positive breast cancer, expert recommendations for treatment selection and sequencing, and how to identify and treat HER2-positive patients with low HER2 expression. For full accreditation information and to register, visit: http://www.rockpointe.com/BreastCancerRegistration

We are pleased to acknowledge Incyte an annual Platinum sponsor. Please welcome and THANK them for supporting your organization, when they call or e-mail you.

Incyte is a global biopharmaceutical company founded on the premise that investment in strong science and the relentless pursuit of R&D excellence can translate into new solutions that can positively affect patients’ lives. For more info, visit:
https://www.incyte.com/what-we-do/therapies-support

Delivering Science | Incyte.com Incyte is a science-driven and patient-focused company, aiming to make a difference for patients, medical professionals, the healthcare community and global stakeholders.

LunchTime Series Webinar on Wednesday, January 19 at 12:30pm-PST. Adam Younger, MBA, Co-Founder and Chief Strategy Officer, PayGround will be discussing “How to Improve the Patient Collections Experience.”
The PayGround platform allows patients to connect with their providers and the ability to pay and track all their healthcare payments in one place. PayGround has already been adopted by multiple MOASC members and the average yearly savings is estimated to be just over $10,000 in the first year. Following the webinar, there will be an opportunity to connect with the team at PayGround and have them run a free rate comparison to discover the possible savings for your practice. Register at [email protected]

We are pleased to join Rockpointe Corp in presenting an on-demand, free CME/CE-certified webcourse on “Nonmelanoma Skin Cancers." This will be available until August of 2022. https://rockpointe.com/courses/nonmelanoma-skin-cancers-current-and-emerging-checkpoint-inhibitors-for-treating-advanced-basal-cell-and-squamous-cell-carcinomas/?utm_source=rp&utm_medium=pm&utm_term=1087

We are pleased to acknowledge Jazz Pharmaceuticals as an annual Platinum sponsor. Jazz Pharmaceuticals is a global biopharmaceutical company whose purpose is to innovate to transform the lives of patients and their families. Read more https://www.jazzpharma.com/about/

About | Jazz Pharmaceuticals Jazz Pharmaceuticals is focused on improving patients’ lives by identifying, developing, and commercializing products that address unmet medical needs.

On December 4, is holding a clinical program entitled "Great Debates in Advanced Cutaneous Squamous Cell Carcinoma." For more information, visit https://medschool.ucsd.edu/education/cme/learners/education/Pages/skin-cancer-2021.aspx

The American Cancer Society Cancer Action Network - California ACS CAN is holding their Virtual Policy Forum on November 18th “Cancer Research Through A Health Equity Lens.” Hear from a group of cancer experts who will share how their work contributes to breakthroughs in cancer treatment, care, and survivorship, and the policies and programs that can ensure that these advances will be available for everyone. Please join us and visit fightcancer.org/equityinresearch to RSVP.

Cancer Research Through A Health Equity Lens Please join us for

In recognition of , join us for a Clinical Webinar on 11/3 at 5:30pm-PT. Dr. Ignatius Ou, UCI, Dr. Aaron Lisberg, UCLA and Dr. Misako Nagasaka, UCI will be discussing the Recent Advances in Lung Cancer. RSVP [email protected]